GlassScriptPhysician profile
Matthew Skalak
NPI 1215557665
$1,425.26
in general payments reported to CMS, 2019-2025
11 companies · $1,209 in 2025
The $1,209 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $216 · 2025: $1,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289 · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.63 |
| Entertainment | $136.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $298.00 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $170.05 | 2025 | Accolade Sr |
| Angiodynamics, INC. | $157.30 | 2025 | Nanoknife |
| Photocure INC | $141.26 | 2025 | Cysview |
| Edap Technomed INC | $136.63 | 2025 | |
| Urogen Pharma, INC. | $125.00 | 2025 | |
| Merck Sharp & Dohme LLC | $111.14 | 2024 | Keytruda |
| Abbvie INC. | $104.99 | 2024 | |
| Blue Earth Diagnostics | $96.97 | 2025 | Posluma |
| Ferring Pharmaceuticals INC. | $67.67 | 2025 | Adstiladrin |
| Integra Lifesciences Corporation | $16.25 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Skalak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.